The US Food and Drug Administration (FDA) has approved Swiss drugmaker Ferring Pharmaceuticals’ Adstiladrin (nadofaragene firedenovec-vncg) for the treatment of adult patients with high-risk ...
Abstract #TPS891 (Poster #J19), Friday, February 14, 11:30 a.m. PST ABLE-32: A randomized, controlled, phase 3B clinical trial of nadofaragene firadenovec-vncg versus observation in patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback